Figure 2.
Overall survival for study population of EORTC 62005 compared with historical controls from EORTC database.
From Verweij J, Casali PG, Zalcberg J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomized trial*. The Lancet. 2004; 364(9440):1127–1134; with permission.